Literature DB >> 15156475

Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children.

Joachim E Fischer1, Stephan Harbarth, Alexander G Agthe, Anne Benn, Steven A Ringer, Donald A Goldmann, Sergio Fanconi.   

Abstract

To determine the diagnostic accuracy of physicians' prior probability estimates of serious infection in critically ill neonates and children, we conducted a prospective cohort study in 2 intensive care units. Using available clinical, laboratory, and radiographic information, 27 physicians provided 2567 probability estimates for 347 patients (follow-up rate, 92%). The median probability estimate of infection increased from 0% (i.e., no antibiotic treatment or diagnostic work-up for sepsis), to 2% on the day preceding initiation of antibiotic therapy, to 20% at initiation of antibiotic treatment (P<.001). At initiation of treatment, predictions discriminated well between episodes subsequently classified as proven infection and episodes ultimately judged unlikely to be infection (area under the curve, 0.88). Physicians also showed a good ability to predict blood culture-positive sepsis (area under the curve, 0.77). Treatment and testing thresholds were derived from the provided predictions and treatment rates. Physicians' prognoses regarding the presence of serious infection were remarkably precise. Studies investigating the value of new tests for diagnosis of sepsis should establish that they add incremental value to physicians' judgment.

Entities:  

Mesh:

Year:  2004        PMID: 15156475     DOI: 10.1086/420741

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Is the role of instinct important in medicine?

Authors:  Salil B Patel
Journal:  J R Soc Med       Date:  2014-12       Impact factor: 5.344

Review 2.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

Review 3.  Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Authors:  Werner C Albrich; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2015-07-21       Impact factor: 17.440

4.  Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.

Authors:  F Dusemund; B Bucher; S Meyer; R Thomann; F Kühn; S Bassetti; M Sprenger; E Baechli; T Sigrist; M Schwietert; D Amin; P Hausfater; E Carre; P Schuetz; J Gaillat; K Regez; R Bossart; U Schild; B Müller; W C Albrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-12       Impact factor: 3.267

5.  Postoperative sepsis in infants below 6 months of age.

Authors:  Ulf Kessler; Marc Ebneter; Zacharias Zachariou; Steffen Berger
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

Review 6.  Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?

Authors:  Arash Afshari; Jacques Schrenzel; Margareta Ieven; Stephan Harbarth
Journal:  Crit Care       Date:  2012-05-29       Impact factor: 9.097

Review 7.  Antimicrobial resistance determinants and future control.

Authors:  Stephan Harbarth; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

Review 8.  Year in review 2010: Critical Care--Infection.

Authors:  Leonardo Pagani; Arash Afshari; Stephan Harbarth
Journal:  Crit Care       Date:  2011-12-05       Impact factor: 9.097

9.  Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.

Authors:  Beat Müller; Stephan Harbarth; Daiana Stolz; Roland Bingisser; Christian Mueller; Jörg Leuppi; Charly Nusbaumer; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2007-03-02       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.